Global

CN EN
  1. HOME
  2. ABOUT US
    About Laekna Core Management Team Board of Directors Milestones Scientific Advisory Board Core Investors Honors & Awards
  3. R&D
    R&D Therapeutic Areas Candidates Pipeline Clinical Trials
  4. PARTNERSHIPS
    Strategic Partners Business Development Holistic Approach BD Contact
  5. INVESTORS
    Corporate Governance Financial Results Announcements and Circulars IR Calendar Listing Documents
  6. NEWS
    Press Releases Media Coverage
  7. CAREERS
    Global Team Career Development Jobs My Laekna
  8. CONTACT US
    Contact Us Leave Message
  9. RSS Feeds
NEWS
PRESS CENTER

Scroll down to see more

Latest Articles
Media Coverage Press Releases
Search
  1. 2025-11-12
    Laekna entered into an exclusive licensing agreement with Qilu Pharma for LAE002 (AFURESERTIB), an innovative drug candidate for the treatment of breast cancer in China
    Laekna entered into an exclusive licensing agreement with Qilu Pharma for LAE002 (AFURESERTIB), an innovative drug candidate for the treatment of breast cancer in China
    More
    More
    More
  2. 2025-10-21
    Voluntary Announcement | Preliminary Results from The Phase I MAD Study LAE102 Demonstrated Encouraging Trend Towards Lean Body Mass Increase and Fat Mass Reduction
    More
  3. 2025-08-14
    Laekna (2105.HK) Announces Interim Results 2025
    More
  4. 2025-07-31
    Laekna Announces IND Approval of LAE103 (an ActRIIB selective antibody) for Sarcopenic Obesity and Muscle Related Disease by FDA
    More
  5. 2025-06-30
    Laekna Submitted Investigational New Drug Application to FDA for LAE103 for Sarcopenic Obesity and Muscle Related Disease
    More
  6. 2025-06-23
    ADA 2025 | Laekna Presented Clinical and Pre-clinical Studies Results of LAE102, LAE103 and LAE123
    More
  7. 2025-05-28
    Laekna Announced First Subject Dosed in Phase I Clinical Trial of LAE102 in U.S. for the Treatment of Obesity
    More
123411
Media contact
communication@laekna.com
RSS Feeds
If you want to know more about Laekna, please fill in the form below and sign up for emails:
  1. Name*
  2. Email*
  3. Company
  4. Occupation

News

Positions

Follow us on Linkedin

  1. HOME
  2. ABOUT US
  3. R&D
  4. PARTNERSHIPS
  5. INVESTORS
  6. NEWS
  7. CAREERS
  8. CONTACT US

Copyright © Laekna Therapeutics, All Rights Reserved.  沪ICP备17047795号 Privacy Policy

Follow us on Linkedin

Follow us on Wechat